Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment

CompletedOBSERVATIONAL
Enrollment

325

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Bacterial Infections
Interventions
DEVICE

Medical device simulation

For the subjects included, investigators used the iAST® tool to predict which antibiotics would have been recommended as the top three choices both for empiric and semi-targeted therapy and recorded this data with the percentage of coverage predicted (the first three antibiotics in the iAST® ranking that have been tested in the antibiogram of the center where the study was carried were chosen). Investigators checked the final microbiological reports and logged if the recovered bacteria were susceptible to the drug prescribed by doctors and simulated by the iAST® tool according to the final antibiogram results.

Trial Locations (1)

28015

Grupo HM Hospitales, Madrid

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NAMSA

OTHER

collaborator

Grupo Hospital de Madrid

OTHER

lead

Pragmatech AI Solutions

INDUSTRY

NCT06174519 - Evaluation of the Artificial Intelligence-based Prescription Support Software iAST® for the Choice of Empirical and Semi-targeted Antibiotic Treatment | Biotech Hunter | Biotech Hunter